BiotechTube
Home/Innoblative Designs/Bob Rioux
BR

Bob Rioux

Chief Technology Officer

Innoblative Designs

Therapeutic Areas

OncologySurgical Oncology

Innoblative Designs Pipeline

DrugIndicationPhase
SIRA® RFA Electrosurgical DeviceAdjunct for margin control in Breast-Conserving Surgery (Lumpectomy)Post-market
Platform DevicesSoft tissue diseases (Oncology)Development

Leadership Team at Innoblative Designs

RS
Richard Stark
Chief Executive Officer
AJ
Ariel Johnson
Chief Financial Officer
KC
Katherine Crowley
VP Regulatory/Quality
AB
Alyssa Bailey
VP Operations
IM
Israel Madera
VP Marketing
KP
Kelly Petrucci
VP Market Access
View full Innoblative Designs profile